• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

朝向预测药物-聚合物无定形固体分散体混溶性、稳定性和制剂设计的分子模拟和统计学习方法。

Molecular Simulation and Statistical Learning Methods toward Predicting Drug-Polymer Amorphous Solid Dispersion Miscibility, Stability, and Formulation Design.

机构信息

VeriSIM Life Inc., 1 Sansome St, Suite 3500, San Francisco, CA 94104, USA.

出版信息

Molecules. 2021 Jan 1;26(1):182. doi: 10.3390/molecules26010182.

DOI:10.3390/molecules26010182
PMID:33401494
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7794704/
Abstract

Amorphous solid dispersions (ASDs) have emerged as widespread formulations for drug delivery of poorly soluble active pharmaceutical ingredients (APIs). Predicting the API solubility with various carriers in the API-carrier mixture and the principal API-carrier non-bonding interactions are critical factors for rational drug development and formulation decisions. Experimental determination of these interactions, solubility, and dissolution mechanisms is time-consuming, costly, and reliant on trial and error. To that end, molecular modeling has been applied to simulate ASD properties and mechanisms. Quantum mechanical methods elucidate the strength of API-carrier non-bonding interactions, while molecular dynamics simulations model and predict ASD physical stability, solubility, and dissolution mechanisms. Statistical learning models have been recently applied to the prediction of a variety of drug formulation properties and show immense potential for continued application in the understanding and prediction of ASD solubility. Continued theoretical progress and computational applications will accelerate lead compound development before clinical trials. This article reviews in silico research for the rational formulation design of low-solubility drugs. Pertinent theoretical groundwork is presented, modeling applications and limitations are discussed, and the prospective clinical benefits of accelerated ASD formulation are envisioned.

摘要

无定形固体分散体(ASD)已成为用于传递难溶性活性药物成分(API)的广泛制剂。在 API-载体混合物中预测各种载体的 API 溶解度和主要 API-载体非键相互作用是合理药物开发和配方决策的关键因素。这些相互作用、溶解度和溶解机制的实验确定既耗时、昂贵,又依赖于反复试验。为此,分子建模已被应用于模拟 ASD 性质和机制。量子力学方法阐明了 API-载体非键相互作用的强度,而分子动力学模拟则用于模拟和预测 ASD 的物理稳定性、溶解度和溶解机制。统计学习模型最近已应用于各种药物配方性质的预测,并为继续应用于 ASD 溶解度的理解和预测显示出巨大的潜力。持续的理论进展和计算应用将加速临床试验前先导化合物的开发。本文综述了用于设计低溶解度药物的合理配方的计算研究。介绍了相关的理论基础,讨论了建模应用和局限性,并设想了加速 ASD 配方的潜在临床益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3d/7794704/edb45f6998bc/molecules-26-00182-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3d/7794704/e9c6b65c4e50/molecules-26-00182-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3d/7794704/edb45f6998bc/molecules-26-00182-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3d/7794704/e9c6b65c4e50/molecules-26-00182-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3d/7794704/edb45f6998bc/molecules-26-00182-g002.jpg

相似文献

1
Molecular Simulation and Statistical Learning Methods toward Predicting Drug-Polymer Amorphous Solid Dispersion Miscibility, Stability, and Formulation Design.朝向预测药物-聚合物无定形固体分散体混溶性、稳定性和制剂设计的分子模拟和统计学习方法。
Molecules. 2021 Jan 1;26(1):182. doi: 10.3390/molecules26010182.
2
Navigating the Solution to Drug Formulation Problems at Research and Development Stages by Amorphous Solid Dispersion Technology.利用无定形固体分散技术解决研发阶段的药物制剂问题。
Recent Adv Drug Deliv Formul. 2024;18(2):79-99. doi: 10.2174/0126673878271641231201065151.
3
Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?将晶型和聚合型辅料组合在原料药固体分散体中-机遇还是风险?
Eur J Pharm Biopharm. 2021 Jan;158:323-335. doi: 10.1016/j.ejpb.2020.11.025. Epub 2020 Dec 6.
4
Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.通过热熔挤出和条粒化制备双聚合物无定形固体分散体的配方性能和可加工窗口。
Int J Pharm. 2018 Dec 20;553(1-2):408-421. doi: 10.1016/j.ijpharm.2018.10.035. Epub 2018 Oct 14.
5
Molecular-Level Examination of Amorphous Solid Dispersion Dissolution.非晶态固体分散体溶解的分子水平研究。
Mol Pharm. 2021 Nov 1;18(11):3999-4014. doi: 10.1021/acs.molpharmaceut.1c00289. Epub 2021 Sep 27.
6
Physical stability of API/polymer-blend amorphous solid dispersions.原料药/聚合物共混无定形固体分散体的物理稳定性。
Eur J Pharm Biopharm. 2018 Mar;124:147-157. doi: 10.1016/j.ejpb.2017.12.002. Epub 2017 Dec 18.
7
Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions.溶剂对无定形固体分散体的相行为和玻璃化转变的影响。
Eur J Pharm Biopharm. 2021 Jan;158:132-142. doi: 10.1016/j.ejpb.2020.11.002. Epub 2020 Nov 16.
8
Recent Advances in Understanding the Micro- and Nanoscale Phenomena of Amorphous Solid Dispersions.理解无定形固体分散体的微观和纳米现象的最新进展。
Mol Pharm. 2019 Oct 7;16(10):4089-4103. doi: 10.1021/acs.molpharmaceut.9b00601. Epub 2019 Sep 5.
9
The Application of Modeling and Prediction to the Formation and Stability of Amorphous Solid Dispersions.建模和预测在无定形固体分散体形成和稳定性中的应用。
J Pharm Sci. 2018 Jan;107(1):57-74. doi: 10.1016/j.xphs.2017.03.029. Epub 2017 Apr 5.
10
Can Pure Predictions of Activity Coefficients from PC-SAFT Assist Drug-Polymer Compatibility Screening?纯从 PC-SAFT 预测活度系数能否有助于药物-聚合物相容性筛选?
Mol Pharm. 2023 Aug 7;20(8):3960-3974. doi: 10.1021/acs.molpharmaceut.3c00124. Epub 2023 Jun 29.

引用本文的文献

1
Physics-Based Solubility Prediction for Organic Molecules.基于物理的有机分子溶解度预测
Chem Rev. 2025 Aug 13;125(15):7057-7098. doi: 10.1021/acs.chemrev.4c00855. Epub 2025 Jul 29.
2
Investigating the Formation and Molecular Solubilization Mechanism of Emodin Solid Dispersions by Molecular Dynamics Simulation.通过分子动力学模拟研究大黄素固体分散体的形成及分子增溶机制
Molecules. 2025 Feb 10;30(4):822. doi: 10.3390/molecules30040822.
3
Quantitative Analysis of Physical Stability Mechanisms of Amorphous Solid Dispersions by Molecular Dynamic Simulation.

本文引用的文献

1
Role of Polymer Excipients in the Kinetic Stabilization of Drug-Rich Nanoparticles.聚合物辅料在富含药物纳米颗粒动力学稳定中的作用
ACS Appl Bio Mater. 2020 Oct 19;3(10):7243-7254. doi: 10.1021/acsabm.0c01173. Epub 2020 Oct 7.
2
A review on genetic algorithm: past, present, and future.关于遗传算法的综述:过去、现在与未来。
Multimed Tools Appl. 2021;80(5):8091-8126. doi: 10.1007/s11042-020-10139-6. Epub 2020 Oct 31.
3
Physical stability of amorphous pharmaceutical solids: Nucleation, crystal growth, phase separation and effects of the polymers.
基于分子动力学模拟的无定形固体分散体物理稳定性机制的定量分析
AAPS J. 2024 Dec 5;27(1):9. doi: 10.1208/s12248-024-01001-w.
4
Predicting the Release Mechanism of Amorphous Solid Dispersions: A Combination of Thermodynamic Modeling and In Silico Molecular Simulation.预测无定形固体分散体的释放机制:热力学建模与计算机分子模拟相结合
Pharmaceutics. 2024 Oct 2;16(10):1292. doi: 10.3390/pharmaceutics16101292.
5
Computational Support to Explore Ternary Solid Dispersions of Challenging Drugs Using Coformer and Hydroxypropyl Cellulose.使用共晶体和羟丙纤维素探索具有挑战性药物的三元固体分散体的计算支持。
Mol Pharm. 2024 Nov 4;21(11):5619-5631. doi: 10.1021/acs.molpharmaceut.4c00592. Epub 2024 Oct 10.
6
Accelerating Formulation Design via Machine Learning: Generating a High-throughput Shampoo Formulations Dataset.通过机器学习加速配方设计:生成高通量洗发水配方数据集
Sci Data. 2024 Jul 3;11(1):728. doi: 10.1038/s41597-024-03573-w.
7
Computer-driven formulation development of Ginsenoside Rh2 ternary solid dispersion.人参皂苷Rh2三元固体分散体的计算机驱动制剂研发
Drug Deliv Transl Res. 2025 Feb;15(2):700-716. doi: 10.1007/s13346-024-01628-4. Epub 2024 Jun 24.
8
Multiscale modelling of transport in polymer-based reverse-osmosis/nanofiltration membranes: present and future.基于聚合物的反渗透/纳滤膜中传输的多尺度建模:现状与未来。
Discov Nano. 2024 May 21;19(1):91. doi: 10.1186/s11671-024-04020-w.
9
Status of Polymer Fused Deposition Modeling (FDM)-Based Three-Dimensional Printing (3DP) in the Pharmaceutical Industry.基于聚合物熔融沉积建模(FDM)的三维打印(3DP)在制药行业中的现状。
Polymers (Basel). 2024 Jan 30;16(3):386. doi: 10.3390/polym16030386.
10
Composition Dependency of the Flory-Huggins Interaction Parameter in Drug-Polymer Phase Behavior.药物-聚合物相行为中弗洛里-哈金斯相互作用参数的组成依赖性
Pharmaceutics. 2023 Nov 21;15(12):2650. doi: 10.3390/pharmaceutics15122650.
无定形药物固体的物理稳定性:成核、晶体生长、相分离以及聚合物的影响。
Int J Pharm. 2020 Nov 30;590:119925. doi: 10.1016/j.ijpharm.2020.119925. Epub 2020 Oct 2.
4
Bioavailability Enhancement of Olmesartan Medoxomil Using Hot-Melt Extrusion: In-Silico, In-Vitro, and In-Vivo Evaluation.利用热熔挤出技术提高奥美沙坦酯的生物利用度:体内外评价。
AAPS PharmSciTech. 2020 Sep 4;21(7):254. doi: 10.1208/s12249-020-01780-3.
5
The coarse-grained models of poly(ethylene oxide) and poly(propylene oxide) homopolymers and poloxamers in big multipole water (BMW) and MARTINI frameworks.多水大偶极子水(BMW)和 MARTINI 框架中聚(氧化乙烯)和聚(氧化丙烯)均聚物以及泊洛沙姆的粗粒度模型。
Phys Chem Chem Phys. 2020 Jul 22;22(28):15976-15985. doi: 10.1039/d0cp01006e.
6
Experimental, Thermodynamic, and Molecular Modeling Evaluation of Amorphous Simvastatin-Poly(vinylpyrrolidone) Solid Dispersions.实验、热力学和分子模拟评估辛伐他汀-聚乙烯吡咯烷酮无定形固体分散体。
Mol Pharm. 2020 Jul 6;17(7):2703-2720. doi: 10.1021/acs.molpharmaceut.0c00413. Epub 2020 Jun 22.
7
Probing the Molecular-Level Interactions in an Active Pharmaceutical Ingredient (API) - Polymer Dispersion and the Resulting Impact on Drug Product Formulation.探究活性药物成分 (API) - 聚合物分散体中的分子间相互作用及其对药物产品配方的影响。
Pharm Res. 2020 May 13;37(6):94. doi: 10.1007/s11095-020-02813-z.
8
Periodic DFT Calculations-Review of Applications in the Pharmaceutical Sciences.周期性密度泛函理论计算——药学领域应用综述
Pharmaceutics. 2020 May 1;12(5):415. doi: 10.3390/pharmaceutics12050415.
9
Multiple approaches for achieving drug solubility: an in silico perspective.实现药物溶解度的多种方法:计算视角。
Drug Discov Today. 2020 Jul;25(7):1206-1212. doi: 10.1016/j.drudis.2020.04.016. Epub 2020 Apr 27.
10
Can We Predict the Pressure Induced Phase Transition of Urea? Application of Quantum Molecular Dynamics.我们能否预测尿素的压力诱导相变?量子分子动力学的应用。
Molecules. 2020 Mar 30;25(7):1584. doi: 10.3390/molecules25071584.